The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2

Monique Mulder; E. de Wit; Louis M. Havekes

doi:10.1016/0005-2760(91)90287-r

ScienceGate Book Chapters

JOURNAL ARTICLE

The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2

Monique Mulder E. de Wit Louis M. Havekes

Year: 1991 Journal: Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Vol: 1081 (3)Pages: 308-314 Publisher: Elsevier BV

DOI: 10.1016/0005-2760(91)90287-r

Get Full-Text PDF Get Analytical Report

Keywords:

Lipoprotein lipase Very low-density lipoprotein Biochemistry Chemistry Cell culture Lipase Low-density lipoprotein receptor-related protein 8 Lipoprotein Enzyme Biology Cholesterol Genetics

Metrics

Cited By

2.86

FWCI (Field Weighted Citation Impact)

Refs

0.90

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Lipid metabolism and disorders

Health Sciences → Medicine → Cardiology and Cardiovascular Medicine

Diabetes and associated disorders

Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics

Diabetes, Cardiovascular Risks, and Lipoproteins

Health Sciences → Medicine → Endocrinology, Diabetes and Metabolism

The binding of human lipoprotein lipase treated VLDL by the human hepatoma cell line HepG2

Metrics

Citation History

Topics

Related Documents

Binding and degradation of human high-density lipoproteins by human hepatoma cell line HepG2

Oxidative Modification of Low-Density Lipoprotein by the Human Hepatoma Cell Line HepG2

Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells

Heparin Induces the Expression of Hepatic Triglyceride Lipase in a Human Hepatoma (HepG2) Cell Line

Catabolism of human low density lipoproteins by human hepatoma cell line HepG2